US-headquartered multinational technology company Honeywell has launched the latest expansion in Honeywell’s Aclar film range Aclar Accel, a thermoformable barrier film for pharmaceutical packaging.
The thermoformable element supports a manufacturing process where heat and pressure are applied to a material to form a specific shape.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Honeywell claims that the Aclar Accel packaging addresses an ‘industry need for faster production and delivery’ offering companies a more cost-effective solution while extending product shelf life and giving a more dense, high-moisture barrier than the cold form foil in aluminium blister packaging.
The announcement follows reports that the pharmaceutical packaging market is expected to double in a decade but may be restricted due to rising packaging costs.
Honeywell vice president and general manager packaging and composites Ken West said: “Pharmaceutical companies are seeking new packaging technologies that allow them to get their drugs to market faster and reduce operational costs and Aclar Accel addresses those needs.
“Companies have trusted Aclar for more than 40 years to provide the highest quality protection for their drugs and Aclar Accel gives them new choices. Now, in addition to the customised options of the original Aclar, they can select standard sizes for packaging with these new films and receive them in half the time.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe range comes in three options; two in clear and one in opaque laminate. Both the original and Aclar 1700 are clear with the former customisable and the latter keeping to the standard size and the Aclar Accel 5400 available in the opaque laminate form.
